Disease-modifying drugs, multiple sclerosis and infection-related healthcare use in British Columbia, Canada: a population-based study.
- DOI
- 10.1016/j.lana.2023.100667
- Published
- 2024-01-06
- Container
- Lancet Reg Health Am
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.lana.2023.100667,
title = {Disease-modifying drugs, multiple sclerosis and infection-related healthcare use in British Columbia, Canada: a population-based study.},
author = {Graf J and Ng HS and Zhu F and Zhao Y and Wijnands JM and Evans C and Fisk JD and Marrie RA and Tremlett H.},
year = {2024},
journal = {Lancet Reg Health Am},
doi = {10.1016/j.lana.2023.100667},
url = {https://doi.org/10.1016/j.lana.2023.100667}
}RIS
TY - JOUR TI - Disease-modifying drugs, multiple sclerosis and infection-related healthcare use in British Columbia, Canada: a population-based study. AU - Graf J AU - Ng HS AU - Zhu F AU - Zhao Y AU - Wijnands JM AU - Evans C AU - Fisk JD AU - Marrie RA AU - Tremlett H. PY - 2024 JO - Lancet Reg Health Am DO - 10.1016/j.lana.2023.100667 UR - https://doi.org/10.1016/j.lana.2023.100667 ER -
APA
J, G., HS, N., F, Z., Y, Z., JM, W., C, E., JD, F., RA, M., & H., T. (2024). Disease-modifying drugs, multiple sclerosis and infection-related healthcare use in British Columbia, Canada: a population-based study.. Lancet Reg Health Am. https://doi.org/10.1016/j.lana.2023.100667
Source records
- europe-pmc · retrieved 2026-09-26T00:38:53.394Z
- doaj · retrieved 2026-09-26T00:38:53.414Z